CHOLESTECH LDX ASPARTATE AMINOTRANSFERASE (AST)— 510(k) K032027

Substantially Equivalent

Cholestech Corp.

FDA 510(k) clearance K032027 for CHOLESTECH LDX ASPARTATE AMINOTRANSFERASE (AST), Substantially Equivalent on 2003-09-05. Applicant: Cholestech Corp.. Device class: 2.

Clearance details

Applicant
Cholestech Corp.
Product code
Code CIS
Device class
Class 2
Regulation
21 CFR 862.1100
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Hayward, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code CIS

view all

More clearances from Cholestech Corp.

view all

Recalls naming K032027

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K032027.

Data sourced from openFDA. This site is unofficial and independent of the FDA.